Shanghai Henlius Biotech, Inc. - Laporan Laba Rugi (TTM)

Shanghai Henlius Biotech, Inc.
HK ˙ SEHK ˙ CNE100003N76
HK$ 81.85 ↑6.25 (8.27%)
2025-09-05
BAHAGING PRESYO
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Shanghai Henlius Biotech, Inc. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 386 588 849 1,111 1,397 1,682 2,010 2,338 2,659 3,215 3,820 4,426 5,008 5,395 5,518 5,641 5,702 5,724 5,761 5,798
Change (%) 52.25 44.52 30.81 25.73 20.47 19.49 16.31 13.70 20.92 18.84 15.85 13.16 7.72 2.28 2.23 1.10 0.39 0.64 0.64
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 151 182 264 345 434 523 565 607 665 845 1,053 1,261 1,458 1,476 1,493 1,510 1,495 1,540 1,476 1,412
Change (%) 21.00 44.76 30.92 25.72 20.46 8.05 7.45 9.62 26.95 24.63 19.76 15.69 1.21 1.14 1.13 -0.97 2.98 -4.14 -4.32
% of Revenue 39.00 30.99 31.05 31.07 31.07 31.07 28.10 25.96 25.03 26.27 27.55 28.48 29.12 27.36 27.06 26.77 26.22 26.90 25.62 24.36
Gross Operating Profit 235 405 586 766 963 1,160 1,446 1,731 1,993 2,370 2,768 3,165 3,550 3,919 4,025 4,131 4,207 4,185 4,285 4,386
Change (%) 72.23 44.41 30.75 25.74 20.47 24.64 19.77 15.13 18.90 16.77 14.36 12.15 10.39 2.70 2.63 1.85 -0.54 2.40 2.35
% of Revenue 61.00 69.01 68.95 68.93 68.93 68.93 71.90 74.04 74.97 73.73 72.45 71.52 70.88 72.64 72.94 73.23 73.78 73.10 74.38 75.64
SG&A 349 436 534 632 716 801 913 1,025 1,248 1,604 1,808 2,011 1,914 2,147 2,225 2,281 2,304 2,283 2,341 2,399
Change (%) 25.00 22.42 18.32 13.38 11.80 14.01 12.29 21.73 28.51 12.69 11.26 -4.84 12.18 3.62 2.53 1.00 -0.91 2.54 2.48
% of Revenue 90.44 74.25 62.90 56.89 51.30 47.61 45.43 43.85 46.95 49.90 47.32 45.44 38.22 39.80 40.32 40.44 40.41 39.88 40.64 41.38
R&D 835 894 924 953 988 1,024 1,065 1,107 1,189 1,395 1,401 1,408 1,309 1,119 1,086 1,053 1,060 1,035 1,087 1,138
Change (%) 7.10 3.29 3.19 3.72 3.59 4.04 3.88 7.48 17.25 0.48 0.48 -7.03 -14.52 -2.92 -3.01 0.62 -2.34 4.98 4.74
% of Revenue 216.33 152.17 108.76 85.79 70.77 60.86 52.99 47.33 44.73 43.38 36.68 31.81 26.13 20.74 19.68 18.67 18.59 18.08 18.86 19.63
OpEx 1,334 1,513 1,721 1,930 2,139 2,348 2,543 2,739 3,171 3,843 4,262 4,680 4,631 4,742 4,804 4,844 4,841 4,858 4,904 4,949
Change (%) 13.35 13.80 12.13 10.82 9.76 8.33 7.69 15.77 21.21 10.88 9.81 -1.04 2.39 1.30 0.85 -0.06 0.34 0.94 0.93
% of Revenue 345.76 257.42 202.70 173.76 153.15 139.54 126.51 117.14 119.27 119.55 111.55 105.74 92.47 87.90 87.06 85.89 84.90 84.86 85.12 85.37
Operating Income -948 -925 -872 -819 -742 -665 -533 -401 -512 -629 -441 -254 377 653 714 796 861 867 857 848
Change (%) -2.48 -5.71 -6.06 -9.40 -10.38 -19.88 -24.81 27.82 22.71 -29.80 -42.45 -248.50 73.15 9.34 11.52 8.15 0.63 -1.04 -1.05
% of Revenue -245.76 -157.42 -102.70 -73.76 -53.15 -39.54 -26.51 -17.14 -19.27 -19.55 -11.55 -5.74 7.53 12.10 12.94 14.11 15.10 15.14 14.88 14.63
Interest Expense -44 -44 -55 -67 -76 -85 -90 -96 -101 -106 -107 -109 -109 -111 -115 -119 -121 -123 -119 -114
Change (%) -0.17 26.78 21.12 12.93 11.92 6.64 6.23 5.60 4.15 1.34 1.32 0.61 1.26 3.94 3.79 1.33 1.70 -3.44 -3.56
% of Revenue -11.34 -7.44 -6.52 -6.04 -5.43 -5.04 -4.50 -4.11 -3.82 -3.29 -2.80 -2.45 -2.18 -2.05 -2.08 -2.11 -2.12 -2.15 -2.06 -1.97
Net Income -1,000 -994 -966 -939 -962 -984 -913 -842 -638 -695 -449 -203 55 546 619 692 742 820 822 824
Change (%) -0.65 -2.72 -2.80 2.38 2.32 -7.20 -7.76 -24.30 9.04 -35.39 -54.77 -127.09 892.13 13.40 11.82 7.12 10.63 0.23 0.23
% of Revenue -259.12 -169.09 -113.81 -84.57 -68.86 -58.49 -45.42 -36.02 -23.98 -21.63 -11.76 -4.59 1.10 10.12 11.22 12.27 13.01 14.33 14.27 14.22

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista